{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:26:45Z","timestamp":1791404805045,"version":"4.3.3"},"reference-count":105,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hematologic malignancies are frequently diagnosed in dogs and result in a spectrum of clinical signs associated with specific disease types. The most frequently encountered hematologic tumors in dogs include lymphoma, lymphoid and myeloid leukemias, and mast cell, plasma cell, and histiocytic neoplasias. Coupled with the heterogeneous presentations of the different categories and subtypes of canine hematologic malignancies, outcomes for these tumors are also variable. Considering this, appropriate treatment options range from active surveillance to curative intent approaches harnessing surgical, chemotherapeutic, and radiation-based modalities. The underlying pathology of many of these diseases bears remarkable resemblance to that of the corresponding diagnosis made in human patients. We introduce some of the pathogenic drivers of canine hematologic cancers alongside their clinical presentations. An overview of standard-of-care therapies for each of these diseases is also provided. As comparative oncology gains recognition as a valuable setting in which to investigate the pathogenesis of neoplasia and provide powerful, clinically relevant, immunocompetent models for the evaluation of novel therapies, the number of clinicians and scientists participating in cancer research involving dogs is expected to increase. This review aims at providing an introductory overview of canine hematologic malignancies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005045","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T21:39:08Z","timestamp":1647985148000},"page":"4073-4084","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Bite-size introduction to canine hematologic malignancies"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-3151","authenticated-orcid":false,"given":"Matthew J.","family":"Atherton","sequence":"first","affiliation":[{"name":"1Department of Clinical Sciences and Advanced Medicine,"},{"name":"2Department of Biomedical Sciences, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-4927","authenticated-orcid":false,"given":"Nicola J.","family":"Mason","sequence":"additional","affiliation":[{"name":"1Department of Clinical Sciences and Advanced Medicine,"},{"name":"3Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"issue":"324","key":"2022071215270991000_B1","doi-asserted-by":"crossref","first-page":"324ps5","DOI":"10.1126\/scitranslmed.aaf0746","article-title":"Perspectives from man\u2019s best friend: National Academy of Medicine\u2019s Workshop on Comparative Oncology","volume":"8","author":"LeBlanc","year":"2016","journal-title":"Sci Transl Med."},{"key":"2022071215270991000_B2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetimm.2015.11.003","article-title":"Cancer immunology and canine malignant melanoma: a comparative review","volume":"169","author":"Atherton","year":"2016","journal-title":"Vet Immunol Immunopathol."},{"issue":"8","key":"2022071215270991000_B3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/07357900009012210","article-title":"Spontaneously occurring tumors of companion animals as models for human cancer","volume":"18","author":"Vail","year":"2000","journal-title":"Cancer Invest."},{"issue":"4","key":"2022071215270991000_B4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1476-5810.2003.00025.x","article-title":"Breed incidence of lymphoma in a UK population of insured dogs","volume":"1","author":"Edwards","year":"2003","journal-title":"Vet Comp Oncol."},{"issue":"2","key":"2022071215270991000_B5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01652176.2016.1152633","article-title":"Canine lymphoma: a review","volume":"36","author":"Zandvliet","year":"2016","journal-title":"Vet Q."},{"key":"2022071215270991000_B6","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1038\/ncomms10460","article-title":"Complex disease and phenotype mapping in the domestic dog","volume":"7","author":"Hayward","year":"2016","journal-title":"Nat Commun."},{"issue":"2","key":"2022071215270991000_B7","doi-asserted-by":"crossref","first-page":"e1004922","DOI":"10.1371\/journal.pgen.1004922","article-title":"Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers","volume":"11","author":"Tonomura","year":"2015","journal-title":"PLoS Genet."},{"issue":"4","key":"2022071215270991000_B8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1476-5829.2011.00317.x","article-title":"Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma","volume":"11","author":"Flood-Knapik","year":"2013","journal-title":"Vet Comp Oncol."},{"key":"2022071215270991000_B9","author":"Raskin","year":"2015","edition":"3rd ed"},{"issue":"2","key":"2022071215270991000_B10","first-page":"169","article-title":"Immunophenotypic characterization of canine lymphoproliferative disorders","volume":"11","author":"Ruslander","year":"1997","journal-title":"In\u00a0Vivo."},{"issue":"12","key":"2022071215270991000_B11","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2460\/javma.1994.205.12.1722","article-title":"Prognostic factors for treatment of malignant lymphoma in dogs","volume":"205","author":"Teske","year":"1994","journal-title":"J Am Vet Med Assoc."},{"issue":"4","key":"2022071215270991000_B12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1354\/vp.42-4-468","article-title":"CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma","volume":"42","author":"Jubala","year":"2005","journal-title":"Vet Pathol."},{"issue":"2","key":"2022071215270991000_B13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0300985819900352","article-title":"Generation and validation of an antibody to canine CD19 for diagnostic and future therapeutic purposes","volume":"57","author":"Haran","year":"2020","journal-title":"Vet Pathol."},{"issue":"3","key":"2022071215270991000_B14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/jvim.12343","article-title":"Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics","volume":"28","author":"Seelig","year":"2014","journal-title":"J Vet Intern Med."},{"issue":"2","key":"2022071215270991000_B15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tvjl.2003.10.009","article-title":"Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy","volume":"167","author":"Ponce","year":"2004","journal-title":"Vet J."},{"key":"2022071215270991000_B16","author":"Swerdlow","year":"2008"},{"issue":"1","key":"2022071215270991000_B17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0300985810379428","article-title":"Classification of canine malignant lymphomas according to the World Health Organization criteria","volume":"48","author":"Valli","year":"2011","journal-title":"Vet Pathol."},{"issue":"5","key":"2022071215270991000_B18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0300985813478210","article-title":"Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival","volume":"50","author":"Valli","year":"2013","journal-title":"Vet Pathol."},{"issue":"4","key":"2022071215270991000_B19","doi-asserted-by":"crossref","first-page":"e0215154","DOI":"10.1371\/journal.pone.0215154","article-title":"Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq","volume":"14","author":"Giannuzzi","year":"2019","journal-title":"PLoS One."},{"issue":"4","key":"2022071215270991000_B20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0300985812465325","article-title":"Molecular profiling reveals prognostically significant subtypes of canine lymphoma","volume":"50","author":"Frantz","year":"2013","journal-title":"Vet Pathol."},{"issue":"9","key":"2022071215270991000_B21","doi-asserted-by":"crossref","first-page":"e72591","DOI":"10.1371\/journal.pone.0072591","article-title":"Comparative gene expression profiling identifies common molecular signatures of NF-\u03baB activation in canine and human diffuse large B cell lymphoma (DLBCL)","volume":"8","author":"Mudaliar","year":"2013","journal-title":"PLoS One."},{"issue":"16","key":"2022071215270991000_B22","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1158\/0008-5472.CAN-12-3546","article-title":"Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL","volume":"73","author":"Richards","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"2022071215270991000_B23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/vco.12374","article-title":"Canine nodal marginal zone lymphoma: descriptive insight into the biological behaviour","volume":"16","author":"Cozzi","year":"2018","journal-title":"Vet Comp Oncol."},{"issue":"4","key":"2022071215270991000_B24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/jvim.12116","article-title":"Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma","volume":"27","author":"O\u2019Brien","year":"2013","journal-title":"J Vet Intern Med."},{"issue":"3","key":"2022071215270991000_B25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/0300985818823668","article-title":"Immunophenotypic characterization of canine splenic follicular-derived B-cell lymphoma","volume":"56","author":"Stein","year":"2019","journal-title":"Vet Pathol."},{"issue":"4","key":"2022071215270991000_B26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/vco.12588","article-title":"Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog","volume":"18","author":"Giannuzzi","year":"2020","journal-title":"Vet Comp Oncol."},{"issue":"24","key":"2022071215270991000_B27","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood."},{"issue":"3","key":"2022071215270991000_B28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/vco.12227","article-title":"Integrated immunohistochemical and DNA copy number profiling analysis provides insight into the molecular pathogenesis of\u00a0canine follicular lymphoma","volume":"15","author":"Thomas","year":"2017","journal-title":"Vet Comp Oncol."},{"issue":"3","key":"2022071215270991000_B29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/vco.12460","article-title":"Canine CD4+\u00a0T-cell lymphoma identified by flow cytometry exhibits a consistent histomorphology and gene expression profile","volume":"17","author":"Harris","year":"2019","journal-title":"Vet Comp Oncol."},{"issue":"2","key":"2022071215270991000_B30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/jvim.12304","article-title":"Flow cytometric characterization and clinical outcome of CD4+\u00a0T-cell lymphoma in dogs: 67 cases","volume":"28","author":"Avery","year":"2014","journal-title":"J Vet Intern Med."},{"issue":"2","key":"2022071215270991000_B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00580-003-0480-4","article-title":"Clinical, morphological and immunological study of 13 cases of canine lymphoblastic lymphoma: comparison with the human entity","volume":"12","author":"Ponce","year":"2003","journal-title":"Comp Clin Pathol."},{"issue":"1","key":"2022071215270991000_B32","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1111\/vco.12343","article-title":"Increased frequency of CD45 negative T cells (T zone cells) in older golden retriever dogs","volume":"16","author":"Hughes","year":"2018","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12864-020-06872-9","article-title":"Genome-wide association analysis of canine T zone lymphoma identifies link to hypothyroidism and a shared association with mast-cell tumors","volume":"21","author":"Labadie","year":"2020","journal-title":"BMC Genomics."},{"key":"2022071215270991000_B34","author":"Owen","year":"1980"},{"issue":"8","key":"2022071215270991000_B35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1439-0442.2002.00458.x","article-title":"A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000)","volume":"49","author":"Jagielski","year":"2002","journal-title":"J Vet Med A Physiol Pathol Clin Med."},{"issue":"5","key":"2022071215270991000_B36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1939-1676.2011.0767.x","article-title":"Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma","volume":"25","author":"Rao","year":"2011","journal-title":"J Vet Intern Med."},{"issue":"6","key":"2022071215270991000_B37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1939-1676.2002.tb02411.x","article-title":"Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma","volume":"16","author":"Garrett","year":"2002","journal-title":"J Vet Intern Med."},{"issue":"1","key":"2022071215270991000_B38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1476-5829.2010.00230.x","article-title":"CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma","volume":"9","author":"Rebhun","year":"2011","journal-title":"Vet Comp Oncol."},{"issue":"3","key":"2022071215270991000_B39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1939-1676.2009.0289.x","article-title":"Asparaginase and MOPP treatment of dogs with lymphoma","volume":"23","author":"Brodsky","year":"2009","journal-title":"J Vet Intern Med."},{"issue":"3","key":"2022071215270991000_B40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/vco.12693","article-title":"Response-based modification of CHOP chemotherapy for canine B-cell lymphoma","volume":"19","author":"Benjamin","year":"2021","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B41","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1038\/s41598-020-68470-9","article-title":"Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment","volume":"10","author":"Mizuno","year":"2020","journal-title":"Sci Rep."},{"issue":"1","key":"2022071215270991000_B42","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1111\/vco.12337","article-title":"Rabacfosadine for relapsed canine B-cell lymphoma: efficacy and adverse event profiles of 2 different doses","volume":"16","author":"Saba","year":"2018","journal-title":"Vet Comp Oncol."},{"issue":"4","key":"2022071215270991000_B43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/vco.12605","article-title":"Rabacfosadine for na\u00efve canine intermediate to large cell lymphoma: efficacy and adverse event profile across three prospective clinical trials","volume":"18","author":"Saba","year":"2020","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jvim.16341","article-title":"Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma","volume":"36","author":"Weishaar","year":"2022","journal-title":"J Vet Intern Med."},{"issue":"1","key":"2022071215270991000_B45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12917-018-1587-9","article-title":"Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma","volume":"14","author":"Sadowski","year":"2018","journal-title":"BMC Vet Res."},{"key":"2022071215270991000_B46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fonc.2020.00023","article-title":"The genetic and molecular basis for canine models of human leukemia and lymphoma","volume":"10","author":"Avery","year":"2020","journal-title":"Front Oncol."},{"issue":"3","key":"2022071215270991000_B47","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/vco.12251","article-title":"Canine acute leukaemia: 50 cases (1989-2014)","volume":"15","author":"Bennett","year":"2017","journal-title":"Vet Comp Oncol."},{"issue":"2-4","key":"2022071215270991000_B48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-2427(99)00051-3","article-title":"An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction","volume":"69","author":"Vernau","year":"1999","journal-title":"Vet Immunol Immunopathol."},{"issue":"2","key":"2022071215270991000_B49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/vco.12377","article-title":"A retrospective review of acute myeloid leukaemia in 35 dogs diagnosed by a combination of morphologic findings, flow cytometric immunophenotyping and cytochemical staining results (2007-2015)","volume":"16","author":"Davis","year":"2018","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exphem.2008.09.005","article-title":"RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias","volume":"37","author":"Usher","year":"2009","journal-title":"Exp Hematol."},{"issue":"1","key":"2022071215270991000_B51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1939-165X.2008.00099.x","article-title":"Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002-2006)","volume":"38","author":"Tasca","year":"2009","journal-title":"Vet Clin Pathol."},{"issue":"1","key":"2022071215270991000_B52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jvim.13814","article-title":"Breed distribution and clinical characteristics of B cell chronic lymphocytic leukemia in dogs","volume":"30","author":"Bromberek","year":"2016","journal-title":"J Vet Intern Med."},{"issue":"1","key":"2022071215270991000_B53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1939-1676.2010.0640.x","article-title":"Immunophenotype predicts survival time in dogs with chronic lymphocytic leukemia","volume":"25","author":"Comazzi","year":"2011","journal-title":"J Vet Intern Med."},{"issue":"1","key":"2022071215270991000_B54","doi-asserted-by":"crossref","first-page":"e0191205","DOI":"10.1371\/journal.pone.0191205","article-title":"Preferential use of unmutated immunoglobulin heavy variable region genes in boxer dogs with chronic lymphocytic leukemia","volume":"13","author":"Rout","year":"2018","journal-title":"PLoS One."},{"issue":"4","key":"2022071215270991000_B55","first-page":"415","article-title":"Diagnosis of canine primary polycythemia and management with hydroxyurea","volume":"180","author":"Peterson","year":"1982","journal-title":"J Am Vet Med Assoc."},{"issue":"3","key":"2022071215270991000_B56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/1040638716689581","article-title":"Atypical chronic myeloid leukemia in a German shepherd dog","volume":"29","author":"Marino","year":"2017","journal-title":"J Vet Diagn Invest."},{"issue":"3","key":"2022071215270991000_B57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5829.2009.00189.x","article-title":"Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukaemia","volume":"7","author":"Adam","year":"2009","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/vco.12440","article-title":"Comparative oncology: the paradigmatic example of canine and human mast cell neoplasms","volume":"17","author":"Willmann","year":"2019","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/vms3.201","article-title":"Comparative aspects of mast cell neoplasia in animals and the role of KIT in prognosis and treatment","volume":"6","author":"Tamlin","year":"2020","journal-title":"Vet Med Sci."},{"issue":"3","key":"2022071215270991000_B60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1439-0442.1967.tb00235.x","article-title":"Pathologic survey of 300 extirpated canine mastocytomas","volume":"14","author":"Hottendorf","year":"1967","journal-title":"Zentralbl Veterin\u00e4rmed A."},{"issue":"3","key":"2022071215270991000_B61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0195-5616(03)00003-2","article-title":"Mast cell tumors in the dog","volume":"33","author":"London","year":"2003","journal-title":"Vet Clin North Am Small Anim Pract."},{"issue":"5","key":"2022071215270991000_B62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/030098588402100503","article-title":"Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs","volume":"21","author":"Patnaik","year":"1984","journal-title":"Vet Pathol."},{"issue":"1","key":"2022071215270991000_B63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0300985810386469","article-title":"Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior","volume":"48","author":"Kiupel","year":"2011","journal-title":"Vet Pathol."},{"issue":"4","key":"2022071215270991000_B64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/vco.12012","article-title":"The utility of staging in canine mast cell tumours","volume":"12","author":"Warland","year":"2014","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/0300985810387446","article-title":"Canine subcutaneous mast cell tumor: characterization and prognostic indices","volume":"48","author":"Thompson","year":"2011","journal-title":"Vet Pathol."},{"issue":"4","key":"2022071215270991000_B66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1354\/vp.41-4-371","article-title":"The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors","volume":"41","author":"Kiupel","year":"2004","journal-title":"Vet Pathol."},{"key":"2022071215270991000_B67","first-page":"49","article-title":"Canine mast cell tumors: diagnosis, treatment, and prognosis","volume":"5","author":"Garrett","year":"2014","journal-title":"Vet Med (Auckl)."},{"issue":"10","key":"2022071215270991000_B68","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2460\/javma.243.10.1436","article-title":"Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012)","volume":"243","author":"Pratschke","year":"2013","journal-title":"J Am Vet Med Assoc."},{"issue":"6","key":"2022071215270991000_B69","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1292\/jvms.68.581","article-title":"Outcome and prognostic factors following adjuvant prednisone\/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases","volume":"68","author":"Thamm","year":"2006","journal-title":"J Vet Med Sci."},{"issue":"3","key":"2022071215270991000_B70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1476-5829.2009.00190.x","article-title":"Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases","volume":"7","author":"Cooper","year":"2009","journal-title":"Vet Comp Oncol."},{"issue":"11","key":"2022071215270991000_B71","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-08-1860","article-title":"Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision","volume":"15","author":"London","year":"2009","journal-title":"Clin Cancer Res."},{"issue":"4","key":"2022071215270991000_B72","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1939-1676.2008.00132.x","article-title":"Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs","volume":"22","author":"Isotani","year":"2008","journal-title":"J Vet Intern Med."},{"issue":"11","key":"2022071215270991000_B73","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood."},{"issue":"10","key":"2022071215270991000_B74","first-page":"468","article-title":"An overview of multiple myeloma in dogs and cats","volume":"104","author":"Sternberg","year":"2009","journal-title":"Vet Med."},{"issue":"3","key":"2022071215270991000_B75","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/vcp.12503","article-title":"A metastatic secretory gastric plasmacytoma with aberrant CD3 expression in a dog","volume":"46","author":"Atherton","year":"2017","journal-title":"Vet Clin Pathol."},{"issue":"3","key":"2022071215270991000_B76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1939-165X.2011.00341.x","article-title":"Waldenstr\u00f6m\u2019s macroglobulinemia in a dog with a bleeding diathesis","volume":"40","author":"Jaillardon","year":"2011","journal-title":"Vet Clin Pathol."},{"issue":"6","key":"2022071215270991000_B77","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/1040638719882045","article-title":"Plasma cell leukemia with plasmablastic morphology in a dog","volume":"31","author":"Dagher","year":"2019","journal-title":"J Vet Diagn Invest."},{"issue":"11","key":"2022071215270991000_B78","first-page":"1313","article-title":"Idiopathic monoclonal (IgA) gammopathy in a dog","volume":"170","author":"Dewhirst","year":"1977","journal-title":"J Am Vet Med Assoc."},{"issue":"10","key":"2022071215270991000_B79","first-page":"477","article-title":"Extramedullary and solitary osseous plasmacytomas in dogs and cats","volume":"104","author":"Sternberg","year":"2009","journal-title":"Vet Med."},{"issue":"2","key":"2022071215270991000_B80","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5326\/0380135","article-title":"Monoclonal gammopathies in the dog: a retrospective study of 18 cases (1986-1999) and literature review","volume":"38","author":"Giraudel","year":"2002","journal-title":"J Am Anim Hosp Assoc."},{"issue":"1","key":"2022071215270991000_B81","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jvim.15967","article-title":"Retrospective evaluation of the use of the International Myeloma Working Group response criteria in dogs with secretory multiple myeloma","volume":"35","author":"Moore","year":"2021","journal-title":"J Vet Intern Med."},{"issue":"4","key":"2022071215270991000_B82","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/jvim.14729","article-title":"Canine cutaneous plasmacytosis: 21 cases (2005-2015)","volume":"31","author":"Boostrom","year":"2017","journal-title":"J Vet Intern Med."},{"issue":"3","key":"2022071215270991000_B83","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/jvim.15084","article-title":"Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs","volume":"32","author":"Fern\u00e1ndez","year":"2018","journal-title":"J Vet Intern Med."},{"issue":"11","key":"2022071215270991000_B84","first-page":"1288","article-title":"Prognostic factors for multiple myeloma in the dog","volume":"188","author":"Matus","year":"1986","journal-title":"J Am Vet Med Assoc."},{"issue":"1","key":"2022071215270991000_B85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0300985813510413","article-title":"A review of histiocytic diseases of dogs and cats","volume":"51","author":"Moore","year":"2014","journal-title":"Vet Pathol."},{"issue":"4","key":"2022071215270991000_B86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcpa.2014.07.003","article-title":"Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats","volume":"151","author":"Pierezan","year":"2014","journal-title":"J Comp Pathol."},{"issue":"10","key":"2022071215270991000_B87","first-page":"1041","article-title":"Canine histiocytic neoplasia: an overview","volume":"48","author":"Fulmer","year":"2007","journal-title":"Can Vet J."},{"issue":"8","key":"2022071215270991000_B88","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jsap.12688","article-title":"Histiocytic sarcoma in 14 miniature schnauzers \u2013 a new breed predisposition?","volume":"58","author":"Lenz","year":"2017","journal-title":"J Small Anim Pract."},{"issue":"3","key":"2022071215270991000_B89","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0300985811398251","article-title":"Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors","volume":"48","author":"Ramos-Vara","year":"2011","journal-title":"Vet Pathol."},{"issue":"4","key":"2022071215270991000_B90","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00262-021-03033-z","article-title":"Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma","volume":"71","author":"Lenz","year":"2022","journal-title":"Cancer Immunol Immunother."},{"issue":"6","key":"2022071215270991000_B91","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/ijc.32991","article-title":"PTPN11 mutations in canine and human disseminated histiocytic sarcoma","volume":"147","author":"H\u00e9dan","year":"2020","journal-title":"Int J Cancer."},{"key":"2022071215270991000_B92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2407-11-201","article-title":"Molecular cytogenetic characterization of canine histiocytic sarcoma: a spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior","volume":"11","author":"Hedan","year":"2011","journal-title":"BMC Cancer."},{"issue":"11","key":"2022071215270991000_B93","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1158\/1535-7163.MCT-17-1273","article-title":"Targeting MEK in a translational model of histiocytic sarcoma","volume":"17","author":"Takada","year":"2018","journal-title":"Mol Cancer Ther."},{"issue":"5","key":"2022071215270991000_B94","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1354\/vp.43-5-632","article-title":"Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+\u00a0macrophages","volume":"43","author":"Moore","year":"2006","journal-title":"Vet Pathol."},{"issue":"2","key":"2022071215270991000_B95","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1939-165X.2008.00042.x","article-title":"Dendritic cell leukemia in a golden retriever","volume":"37","author":"Allison","year":"2008","journal-title":"Vet Clin Pathol."},{"issue":"6","key":"2022071215270991000_B96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/vde.12147","article-title":"Multiple cutaneous histiocytomas treated with lomustine in a dog","volume":"25","author":"Maina","year":"2014","journal-title":"Vet Dermatol."},{"issue":"2","key":"2022071215270991000_B97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5829.2009.00186.x","article-title":"Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy","volume":"7","author":"Skorupski","year":"2009","journal-title":"Vet Comp Oncol."},{"issue":"4","key":"2022071215270991000_B98","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/vco.12609","article-title":"Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: an Italian Society of Veterinary Oncology study","volume":"18","author":"Marconato","year":"2020","journal-title":"Vet Comp Oncol."},{"issue":"1","key":"2022071215270991000_B99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"Skorupski","year":"2007","journal-title":"J Vet Intern Med."},{"issue":"4","key":"2022071215270991000_B100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/vco.12252","article-title":"Clinical prognostic factors in canine histiocytic sarcoma","volume":"15","author":"Dervisis","year":"2017","journal-title":"Vet Comp Oncol."},{"issue":"9","key":"2022071215270991000_B101","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2016.146","article-title":"Feasibility and safety of RNA-transfected CD20-specific chimeric antigen receptor T cells in dogs with spontaneous B cell lymphoma","volume":"24","author":"Panjwani","year":"2016","journal-title":"Mol Ther."},{"issue":"1","key":"2022071215270991000_B102","doi-asserted-by":"crossref","first-page":"1676615","DOI":"10.1080\/2162402X.2019.1676615","article-title":"Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma","volume":"9","author":"Panjwani","year":"2019","journal-title":"Oncoimmunology."},{"issue":"4","key":"2022071215270991000_B103","doi-asserted-by":"crossref","first-page":"100905","DOI":"10.1016\/j.xpro.2021.100905","article-title":"Genetic re-direction of canine primary T\u00a0cells for clinical trial use in pet dogs with spontaneous cancer","volume":"2","author":"Rotolo","year":"2021","journal-title":"STAR Protoc."},{"issue":"1","key":"2022071215270991000_B104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity."},{"key":"2022071215270991000_B105","doi-asserted-by":"crossref","first-page":"e50740","DOI":"10.7554\/eLife.50740","article-title":"Preclinical murine tumor models: a structural and functional perspective","volume":"9","author":"Guerin","year":"2020","journal-title":"Elife."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/4073\/1907029\/advancesadv2021005045c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/4073\/1907029\/advancesadv2021005045c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T20:50:09Z","timestamp":1726865409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/13\/4073\/484452\/Bite-size-introduction-to-canine-hematologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":105,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,7,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005045","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}